Neurology · 1977 · 619 citations · 0 references
Life SciencesNeurosciencePharmacologyCognitive NeuroscienceMemorySynaptic PlasticityCholinergic NeurochemistryCholinergic PharmacologyCholinergic SignalingCognitive ImpairmentNeurotransmissionSynaptic TransmissionAcetylcholine PharmacologyCholinergic CircuitsCholinergic ModulationCholinergic Modulation Of CognitionCholinergic Modulation Of MemoryCognitive Enhancement By Cholinergic AgentsLimbic System ModulationLimbic System Organization
Interference with cholinergic function produces disruption of memory/cognitive (M/C) performance in both animals and man. It is uncertain whether this disruption is due to a specific relation of cholinergic neurons to M/C functions, or whether the effect is nonspecific, resulting either from alteration of alertness and attention, or from a "mass action" effect, with loss of functioning neurons. Scopolamine was given to normal subjects to produce an M/C impairment. Half the test subjects then received physostigmine and half d-amphetamine. Physostigmine, a pharmacologic antagonist of scopolamine, markedly improved M/C functions; amphetamine failed to produce M/C improvement, although alertness was improved, and activity in catecholaminergic neurons presumably increased. This comparison supports a specific role for cholinergic neurons in M/C processes. Possible mechanisms of cholinergic neural functioning in memory include plasticity of cholinergic synapses, as well as other acetylcholine-depended operations of the limbic system crucial to memory.